These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31419399)

  • 1. Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds.
    Ryu S; Riccardi K; Patel R; Zueva L; Burchett W; Di L
    J Pharm Sci; 2019 Nov; 108(11):3745-3749. PubMed ID: 31419399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method.
    Ryu S; Tess D; Di L
    AAPS J; 2022 Dec; 25(1):7. PubMed ID: 36471200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs.
    Di L; Breen C; Chambers R; Eckley ST; Fricke R; Ghosh A; Harradine P; Kalvass JC; Ho S; Lee CA; Marathe P; Perkins EJ; Qian M; Tse S; Yan Z; Zamek-Gliszczynski MJ
    J Pharm Sci; 2017 Dec; 106(12):3442-3452. PubMed ID: 28927987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the importance of plasma protein binding in drug discovery and development.
    Di L
    Expert Opin Drug Discov; 2021 Dec; 16(12):1453-1465. PubMed ID: 34403271
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Protein Binding of Challenging Compounds.
    Riccardi K; Cawley S; Yates PD; Chang C; Funk C; Niosi M; Lin J; Di L
    J Pharm Sci; 2015 Aug; 104(8):2627-36. PubMed ID: 26037784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs.
    Zamek-Gliszczynski MJ; Ruterbories KJ; Ajamie RT; Wickremsinhe ER; Pothuri L; Rao MV; Basavanakatti VN; Pinjari J; Ramanathan VK; Chaudhary AK
    J Pharm Sci; 2011 Jun; 100(6):2498-507. PubMed ID: 21213309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.
    Isbell J; Yuan D; Torrao L; Gatlik E; Hoffmann L; Wipfli P
    J Pharm Sci; 2019 Feb; 108(2):1053-1060. PubMed ID: 30336155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.
    Dimitrijevic D; Fabian E; Funk-Weyer D; Landsiedel R
    Biochem Biophys Res Commun; 2023 Apr; 651():114-120. PubMed ID: 36812744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enabling direct and definitive free fraction determination for highly-bound compounds in protein binding assay.
    Zhang J; Pikul G; Horch J; Konovalov D; Li S; Cvijic ME; Shou W; Weller H
    J Pharm Biomed Anal; 2021 Feb; 194():113765. PubMed ID: 33272788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to measure protein binding of enzymatically unstable compounds in plasma.
    Ye Z; Gao H
    Bioanalysis; 2018 Apr; 10(7):451-459. PubMed ID: 29633861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of in vitro and in vivo plasma protein binding using ultracentrifugation and UPLC-tandem mass spectrometry.
    Srikanth CH; Chaira T; Sampathi S; V B S; Bambal RB
    Analyst; 2013 Oct; 138(20):6106-16. PubMed ID: 23964358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.
    Yu G; Zhou HH; Zheng QS; Li GF
    Eur J Clin Pharmacol; 2019 Apr; 75(4):543-551. PubMed ID: 30569284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.
    Li GF; Yu G; Li Y; Zheng Y; Zheng QS; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1948-1956. PubMed ID: 29518400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the accuracy of unbound fraction measurement of drug-protein binding by preconditioning the RED membrane inserts.
    Ye Z; Chen Q
    Bioanalysis; 2020 Dec; 12(23):1699-1708. PubMed ID: 33179537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.